The Associations between Evacuation Status and Lifestyle-Related Diseases in Fukushima after the Great East Japan Earthquake: The Fukushima Health Management Survey.
Great East Japan earthquake
cardiovascular and metabolic diseases
disaster
disease prevalence status
evacuation
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
06 05 2022
06 05 2022
Historique:
received:
28
03
2022
revised:
03
05
2022
accepted:
05
05
2022
entrez:
14
5
2022
pubmed:
15
5
2022
medline:
18
5
2022
Statut:
epublish
Résumé
This study aimed to investigate the association between evacuation status and lifestyle-related disease risks among Fukushima residents following the Great East Japan earthquake. Fukushima health management survey respondents were classified into non-evacuees, returnees, evacuees in lifted areas, and evacuees in banned areas. During a seven-year follow-up, 22,234 men and 31,158 women were included. Those with a history of diabetes, hypertension, or dyslipidemia at baseline were excluded. The odds ratios of risk factors (ORs) and 95% confidence intervals (CIs) for diabetes, hypertension, and dyslipidemia were calculated using a logistic regression model. Spatial autocorrelation of the prevalence of these diseases in the Fukushima area in 2017, was calculated to detect the disease prevalence status. The risks of diabetes, hypertension, and dyslipidemia were higher in evacuees in banned areas than in non-evacuees; the multivariable ORs were 1.32 (95% CI: 1.19-1.46), 1.15 (1.06-1.25), and 1.20 (1.11-1.30) for diabetes, hypertension, and dyslipidemia, respectively. Returnees and evacuees in lifted areas had no increased risk of diseases. The area analyzed had a non-uniform spatial distribution of diabetes, hypertension, and hyperlipidemia, with clusters around Fukushima and Koriyama. Our findings imply the need for continuous support for evacuees in banned areas.
Sections du résumé
BACKGROUND
This study aimed to investigate the association between evacuation status and lifestyle-related disease risks among Fukushima residents following the Great East Japan earthquake.
METHODS
Fukushima health management survey respondents were classified into non-evacuees, returnees, evacuees in lifted areas, and evacuees in banned areas. During a seven-year follow-up, 22,234 men and 31,158 women were included. Those with a history of diabetes, hypertension, or dyslipidemia at baseline were excluded. The odds ratios of risk factors (ORs) and 95% confidence intervals (CIs) for diabetes, hypertension, and dyslipidemia were calculated using a logistic regression model. Spatial autocorrelation of the prevalence of these diseases in the Fukushima area in 2017, was calculated to detect the disease prevalence status.
RESULTS
The risks of diabetes, hypertension, and dyslipidemia were higher in evacuees in banned areas than in non-evacuees; the multivariable ORs were 1.32 (95% CI: 1.19-1.46), 1.15 (1.06-1.25), and 1.20 (1.11-1.30) for diabetes, hypertension, and dyslipidemia, respectively. Returnees and evacuees in lifted areas had no increased risk of diseases. The area analyzed had a non-uniform spatial distribution of diabetes, hypertension, and hyperlipidemia, with clusters around Fukushima and Koriyama.
CONCLUSION
Our findings imply the need for continuous support for evacuees in banned areas.
Identifiants
pubmed: 35565055
pii: ijerph19095661
doi: 10.3390/ijerph19095661
pmc: PMC9105675
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
J Orthop Sci. 2016 Mar;21(2):138-42
pubmed: 26823115
JAMA Netw Open. 2019 Dec 2;2(12):e1917550
pubmed: 31834397
Science. 2011 Dec 2;334(6060):1240
pubmed: 22144619
J Environ Radioact. 2012 Sep;111:13-7
pubmed: 22119330
Fukushima J Med Sci. 2021;67(2):71-82
pubmed: 34456222
Interact J Med Res. 2013 Dec 20;2(2):e31
pubmed: 24362519
Hypertension. 2016 Sep;68(3):558-64
pubmed: 27480836
Biometrika. 1950 Jun;37(1-2):17-23
pubmed: 15420245
J Diabetes Res. 2015;2015:627390
pubmed: 26106625
Curr Hypertens Rev. 2016;12(3):203-214
pubmed: 28034357
Sleep Med. 2020 Apr;68:63-70
pubmed: 32028228
Health Rep. 2009 Mar;20(1):21-8
pubmed: 19388365
Metabol Open. 2020 Jul 17;7:100042
pubmed: 32812914
Environ Health Prev Med. 2020 Jun 11;25(1):19
pubmed: 32527213
BMC Public Health. 2018 Jun 13;18(1):728
pubmed: 29895286
J Clin Epidemiol. 1988;41(11):1125-34
pubmed: 3256304
J Epidemiol. 2012;22(5):375-83
pubmed: 22955043
Int Heart J. 2019 Nov 30;60(6):1253-1258
pubmed: 31666454
J Hypertens. 2020 Jun;38(6):982-1004
pubmed: 32371787
J Trace Elem Med Biol. 2020 Mar 19;61:126497
pubmed: 32247247
BMC Public Health. 2017 Apr 20;17(1):340
pubmed: 28427361
Psychosom Med. 1995 Mar-Apr;57(2):165-76
pubmed: 7792375
JAMA Netw Open. 2020 Sep 1;3(9):e2018339
pubmed: 32990742
Intern Med. 2016;55(15):1967-76
pubmed: 27477401
Am J Epidemiol. 2019 Jun 1;188(6):1109-1119
pubmed: 30874714
Nat Rev Endocrinol. 2017 Sep;13(9):547-560
pubmed: 28664919
Ann Med. 2000 May;32(4):239-51
pubmed: 10852140
Diabetes Metab. 2019 Jun;45(3):312-315
pubmed: 29097002
Stress. 2013 Mar;16(2):233-43
pubmed: 22894170
J Atheroscler Thromb. 2018 Sep 1;25(9):846-984
pubmed: 30135334
BMJ Open. 2017 Jun 23;7(6):e014077
pubmed: 28645951
Nephron Clin Pract. 2010;116(4):c322-5
pubmed: 20664287
Tohoku J Exp Med. 2019;248(4):239-252
pubmed: 31406089
Psychiatry Clin Neurosci. 2016 Aug;70(8):318-31
pubmed: 27192947
J Diabetes Investig. 2020 Jul;11(4):1020-1076
pubmed: 33021749
Psychiatry Res. 2019 Mar;273:171-177
pubmed: 30654301